Keyphrases
Older People
100%
Physical Disability
100%
Spironolactone
100%
Physical Performance
100%
No Significant Difference
50%
Confidence Interval
50%
Muscle Function
50%
EQ-5D
50%
Quality of Life
50%
Heart Failure
50%
Physical Function
50%
Placebo Groups
50%
6-minute Walk Distance (6MWD)
50%
Activities of Daily Living
25%
Between-group
25%
Placebo
25%
Possible Mechanisms
25%
Randomized Placebo-controlled Trial
25%
Mean Group
25%
Functional Limitations
25%
Functional Impairment
25%
Reported Problems
25%
Later Life
25%
Hospital Anxiety
25%
Depression Scale
25%
Anxiety Scale
25%
Group Transformation
25%
Renin-angiotensin-aldosterone System
25%
Community-dwelling
25%
Aldosterone Blockade
25%
Mean Standard Deviation
25%
Timed Up-and-go Test
25%
Incremental Shuttle Walk Test
25%
Medicine and Dentistry
Placebo
100%
Physical Disability
100%
Spironolactone
100%
Physical Performance
100%
Quality of Life
50%
Muscle Function
50%
Walking Distance
50%
Congestive Heart Failure
50%
Activities of Daily Living
25%
Drug Therapy
25%
Functional Limitation
25%
Renin Angiotensin Aldosterone System
25%
Aldosterone
25%
Hospital Anxiety and Depression Scale
25%
Timed Up and Go Test
25%
Incremental Shuttle Walk Test
25%
Nursing and Health Professions
Placebo
100%
Physical Disability
100%
Spironolactone
100%
Confidence Interval
50%
Quality of Life
50%
Walking Distance
50%
Congestive Heart Failure
50%
Aldosterone
50%
Drug Therapy
25%
Hospital Anxiety and Depression Scale
25%
Angiotensin
25%
Renin
25%
Timed Up and Go Test
25%
Incremental Shuttle Walk Test
25%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Spironolactone
100%
Physical Disability
100%
Aldosterone
50%
Congestive Heart Failure
50%
Renin
25%
Angiotensin
25%